Close

Paratek (PRTK) Says Omadacycline Received Qualified Infectious Disease Product Designation from FDA for Additional Indication

September 21, 2017 8:03 AM EDT Send to a Friend
Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login